Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Columbia cancer researchers are working to increase the representation of people of color in cancer clinical trials and decrease the health equity gap, with the help of Stand Up to Cancer.
Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients.
Using a new technique that uncovers the hidden tricks cancer cells use to resist immunotherapy, Columbia and MIT researchers have discovered why some melanoma patients do not respond to the therapy.
Specialized psychosocial interventions—including meaning-centered psychotherapy—can greatly improve a cancer patient's quality of life and reduce suffering.
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.
Restoring an enzyme that maintains the way chromosomes are packed inside cells may lead to new therapies for some blood cancers, according to a new study by Columbia researchers.